These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9703278)

  • 1. Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients.
    Larsson R; Dhar S; Ehrsson H; Nygren P; Lewensohn R
    Br J Cancer; 1998 Aug; 78(3):328-35. PubMed ID: 9703278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of the alkylating oligopeptides J1 (L-melphalanyl-p-L-fluorophenylalanine ethyl ester) and P2 (L-prolyl-m-L-sarcolysyl-p-L-fluorophenylalanine ethyl ester): comparison with melphalan.
    Gullbo J; Dhar S; Luthman K; Ehrsson H; Lewensohn R; Nygren P; Larsson R
    Anticancer Drugs; 2003 Sep; 14(8):617-24. PubMed ID: 14501383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of the novel melphalan containing tripeptide J3 (L-prolyl-L-melphalanyl-p-L-fluorophenylalanine ethyl ester): comparison with its m-L-sarcolysin analogue P2.
    Gullbo J; Wallinder C; Tullberg M; Lövborg H; Ehrsson H; Lewensohn R; Nygren P; Luthman K; Larsson R
    Mol Cancer Ther; 2003 Dec; 2(12):1331-9. PubMed ID: 14707274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased toxicity and DNA cross-linking by peptide bound m-L-sarcolysin (Peptichemio) as compared to melphalan and m-L-sarcolysin in human melanoma cell lines.
    Lewensohn R; Ehrsson H; Hansson J; Ringborg U
    Anticancer Res; 1991; 11(1):321-4. PubMed ID: 2018366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of peptide bound m-L-sarcolysin (peptichemio) on melphalan resistant human myeloma cells in vitro.
    Lewensohn R; Fernberg JO; Ehrsson H; Merlini G
    Med Oncol Tumor Pharmacother; 1991; 8(4):265-9. PubMed ID: 1820493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity and DNA cross-linking induced by peptide conjugated m-L-sarcolysin in human melanoma cells.
    Hansson J; Lewensohn R; Ringborg U
    Anticancer Res; 1991; 11(5):1725-30. PubMed ID: 1768043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential DNA cross-linking and cytotoxicity in PHA-stimulated human lymphocytes exposed to melphalan, m-L-sarcolysin and peptichemio.
    Lewensohn R; Hansson J; Ringborg U; Ehrsson H
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):783-8. PubMed ID: 3653195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivatives of melphalan designed to enhance drug accumulation in cancer cells.
    Kupczyk-Subotkowska L; Tamura K; Pal D; Sakaeda T; Siahaan TJ; Stella VJ; Borchardt RT
    J Drug Target; 1997; 4(6):359-70. PubMed ID: 9239576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cytotoxicity of peptichemio compared to melphalan and meta-DL-sarcolysin.
    Morasca L; Erba E
    Eur J Cancer (1965); 1980 Aug; 16(8):1105-9. PubMed ID: 7439225
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide.
    Roboz J; Jiang J; Holland JF; Bekesi JG
    Cancer Res; 1997 Nov; 57(21):4795-802. PubMed ID: 9354441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of peptichemio in myeloma patients: release of m-L-sarcolysin in vivo and in vitro.
    Ehrsson H; Lewensohn R; Wallin I; Hellström M; Merlini G; Johansson B
    Cancer Chemother Pharmacol; 1993; 31(4):265-8. PubMed ID: 8422688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of melphalan resistance in glioma cells with a peripheral benzodiazepine receptor ligand-melphalan conjugate.
    Kupczyk-Subotkowska L; Siahaan TJ; Basile AS; Friedman HS; Higgins PE; Song D; Gallo JM
    J Med Chem; 1997 May; 40(11):1726-30. PubMed ID: 9171882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity and effect on collagen biosynthesis of proline analogue of melphalan as a prolidase-convertible prodrug in cultured human skin fibroblasts.
    Chrzanowski K; Bielawska A; Bielawski K; Wołczyński S; Pałka J
    Farmaco; 2001 Sep; 56(9):701-6. PubMed ID: 11680815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical modification of melphalan as a key to improving treatment of haematological malignancies.
    Gajek A; Poczta A; Łukawska M; Cecuda-Adamczewska V; Tobiasz J; Marczak A
    Sci Rep; 2020 Mar; 10(1):4479. PubMed ID: 32161295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione and glutathione S-transferases in a human plasma cell line resistant to melphalan.
    Gupta V; Singh SV; Ahmad H; Medh RD; Awasthi YC
    Biochem Pharmacol; 1989 Jun; 38(12):1993-2000. PubMed ID: 2742603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of new anticancer drugs, exemplified by vinorelbine, using the fluorometric microculture cytotoxicity assay on human tumor cell lines and patient biopsy cells.
    Fridborg H; Nygren P; Dhar S; Csoka K; Kristensen J; Larsson R
    J Exp Ther Oncol; 1996 Sep; 1(5):286-95. PubMed ID: 9414416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-damage in human cells treated with the closely related alkylating agents peptichemio, m-L-sarcolysin and melphalan.
    Ringborg U; Lambert B; Lewensohn R; Turesson I
    Eur J Cancer Clin Oncol; 1981 Sep; 17(9):991-6. PubMed ID: 7198989
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of the preparation "Peptichemio" on leukopoiesis and experimental tumours of animals compared with that of sarcolysin and thiophosphamide.
    Balitsky KP; Veksler IG; Tsapenko VF; Kavetsky RE
    G Ital Chemioter; 1980; 27(1):1-5. PubMed ID: 6793439
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of an antitumor multipeptide complex on immunocompetent and antigen-responsive cells.
    De Barbieri A; Golferini A; Brugo A; Omesso A; Tassi GC
    Boll Ist Sieroter Milan; 1976 Jul; 55(3):201-15. PubMed ID: 1087883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic activity of topotecan in human tumour cell lines and primary cultures of human tumour cells from patients.
    Jonsson E; Fridborg H; Csóka K; Dhar S; Sundström C; Nygren P; Larsson R
    Br J Cancer; 1997; 76(2):211-9. PubMed ID: 9231921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.